Cc. Yan et Rj. Huxtable, EFFECT OF THE PYRROLIZIDINE ALKALOID, MONOCROTALINE, ON BILE COMPOSITION OF THE ISOLATED, PERFUSED-RAT-LIVER, Life sciences, 57(6), 1995, pp. 617-626
Citations number
32
Categorie Soggetti
Biology,"Medicine, Research & Experimental","Pharmacology & Pharmacy
Monocrotaline is a hepatotoxic pyrrolizidine alkaloid, releasing high
levels of metabolites into bile of isolated, perfused liver. Although
perfusion of rat liver with 0.5 mM monocrotaline does not affect bile,
flow over a 1 hr study period, it markedly affects bile composition.
Biliary release of conjugated and free GSH increases 30-fold. Marked i
ncreases are also observed in the biliary concentration of the related
sulfur-containing substances, cysteine and cysteinylglycine. However,
biliary release of the sulfur amino acids, taurine and methionine, is
unaffected. Only two amino acids show mildly increased releases, 23%
for glycine and 46% for aspartate. Release of bile acids, cholesterol
and phospholipids also decrease both in terms of mM concentration in b
ile and in terms of nmol secreted per g liver. Thus, exposure to monoc
rotaline causes disturbances in sulfur metabolism in the liver and in
the composition of bile. The consequences for the digestive properties
of bile and gastrointestinal toxicity remain to be established. As su
lfhydryl compounds are involved in detoxification of monocrotaline met
abolites, these findings indicate a mutual interaction of pyrrolizidin
e toxicity and sulfur metabolism. This suggests that dietary sulfur am
ino acid intake may influence susceptibility to pyrrolizidine poisonin
g.